Molecular Cancer Therapeutics, 1538-8514

Tidskrift

Fler filtreringsmöjligheter
  1. 2016
  2. 2015
  3. Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.

    Chen, Y., Zhang, P., Xu, S-C., Yang, L., Ulrikke Voss, Eva Ekblad, Wu, Y., Min, Y., Erik Hertervig, Åke Nilsson & Rui-Dong Duan, 2015, I : Molecular Cancer Therapeutics. 14, 1, s. 259-267

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

    Christiansson, L., Soderlund, S., Mangsbo, S., Hjorth-Hansen, H., Hoglund, M., Markevarn, B., Johan Richter, Stenke, L., Mustjoki, S., Loskog, A. & Olsson-Stromberg, U., 2015, I : Molecular Cancer Therapeutics. 14, 5, s. 1181-1191

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2014
  6. Epidermal Growth Factor-like Domain 7 Predicts Response to First-Line Chemotherapy and Bevacizumab in Patients with Metastatic Colorectal Cancer.

    Hansen, T. F., Nielsen, B. S., Sørensen, F. B., Anders Johnsson & Jakobsen, A., 2014, I : Molecular Cancer Therapeutics. 13, 9, s. 2238-2245

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2012
  8. Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K

    Munck, J. M., Batey, M. A., Zhao, Y., Jenkins, H., Richardson, C. J., Cano, C., Tavecchio, M., Barbeau, J., Bardos, J., Cornell, L., Griffin, R. J., Menear, K., Slade, A., Thommes, P., Martin, N. M. B., Newell, D. R., Smith, G. C. M. & Curtin, N. J., 2012 aug, I : Molecular Cancer Therapeutics. 11, 8, s. 1789-98

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2011
  10. Global microRNA analysis of the NCI-60 cancer cell panel

    Rolf Søkilde, Kaczkowski, B., Podolska, A., Cirera, S., Gorodkin, J., Møller, S. & Litman, T., 2011 mar, I : Molecular Cancer Therapeutics. 10, 3, s. 375-84 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2009
  12. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

    Forni, C., Minuzzo, M., Virdis, E., Tamborini, E., Simone, M., Tavecchio, M., Erba, E., Grosso, F., Gronchi, A., Aman, P., Casali, P. G., D'Incalci, M., Pilotti, S. & Mantovani, R., 2009 feb, I : Molecular Cancer Therapeutics. 8, 2, s. 449-57 9 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells.

    Pettersson, H., Alexander Pietras, Thorén, M., Jenny Karlsson, Johansson, L., Shoshan, M. C. & Sven Påhlman, 2009, I : Molecular Cancer Therapeutics. 8, 1, s. 160-170

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2008
  15. Atypical retinoids ST1926 and CD437 are S-phase-specific agents causing DNA double-strand breaks: significance for the cytotoxic and antiproliferative activity

    Valli, C., Paroni, G., Di Francesco, A. M., Riccardi, R., Tavecchio, M., Erba, E., Boldetti, A., Gianni', M., Fratelli, M., Pisano, C., Merlini, L., Antoccia, A., Cenciarelli, C., Terao, M. & Garattini, E., 2008 sep, I : Molecular Cancer Therapeutics. 7, 9, s. 2941-54

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2007
  17. Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells

    Cetinkaya, C., Hultquist, A., Su, Y., Wu, S., Bahram, F., Sven Påhlman, Guzhova, I. & Larsson, L-G., 2007, I : Molecular Cancer Therapeutics. 6, 10, s. 2634-2641

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumor cells.

    Katrin Mani, Sandgren, S., Welch, J., Fang Cheng, Svensson, K., Lo Persson & Mattias Belting, 2007, I : Molecular Cancer Therapeutics. 6, 2, s. 782-788

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2005
  20. Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.

    Jenny Karlsson, Edsjö, A., Sven Påhlman & Pettersson, H., 2005, I : Molecular Cancer Therapeutics. 4, 7, s. 1128-1135

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. 2004
  22. Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.

    Sofia Gruvberger, Patrik Edén, Markus Ringnér, Bo Baldetorp, Chebil, G., Åke Borg, Mårten Fernö, Peterson, C. & Meltzer, P. S., 2004, I : Molecular Cancer Therapeutics. 3, 2, s. 161-168

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer

    Janssen, S., Jakobsen, C. M., Rosen, D. M., Ricklis, R. M., Reineke, U., Christensen, S. B., Hans Lilja & Denmeade, S. R., 2004, I : Molecular Cancer Therapeutics. 3, 11, s. 1439-1450

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. 2003
  25. Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro

    Khazenzon, N. M., Ljubimov, A. V., Lakhter, A. J., Fujita, M., Fujiwara, H., Sekiguchi, K., Sorokin, L., Petajaniemi, N., Virtanen, I., Black, K. L. & Ljubimova, J. Y., 2003, I : Molecular Cancer Therapeutics. 2, 10, s. 985-994

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease

    Kees, U. R., Ford, J., Watson, M., Murch, A., Markus Ringnér, Walker, R. L. & Meltzer, P., 2003, I : Molecular Cancer Therapeutics. 2, 7, s. 671-677

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift